Eksternt arrangement



Seminar – Publicly Listing a Life Sciences Company in Copenhagen, New York and Stockholm



Sted:Plesner, Amerika Plads 37, 2100 København Ø



Seminar – Publicly Listing a Life Sciences Company in Copenhagen, New York and Stockholm

Sted: Plesner, Amerika Plads 37, 2100 København Ø


On the 7 March 2018 here at Plesner (4.30pm CET and few hours), we are having a great get-together for decision makers, investors and limited number of advisors at a seminar arranged by Nasdaq, Dechert and Plesner. 

How to navigate the listing process
The past few years have witnessed a growing number of Nordic life sciences companies tap the capital markets of Copenhagen, New York and Stockholm.

The paradigm for how Nordic life sciences companies have traditionally achieved financial exits for their investors in this region is changing, with more companies today seeking to publicly list their shares, sometimes even on more than one stock exchange. How are the life sciences capital markets working today, and what can be done to best prepare a Nordic life sciences company for a public listing?

This seminar, with contributions from leading industry experts, will examine the critical issues that executive management teams at life sciences companies must contemplate in advance of a public listing. We will also examine key licensing and collaboration structures and transactions that are often put in place in advance of and in support of successful public offerings.

Seminar topics

  • Why is the Nordic region a center for global life sciences activity?
  • How is the Nordic investment community evolving to guide life sciences companies to publicly list?
  • Will the growing number of public listings of life sciences companies attract more global venture capital investment to the region?
  • What do the licensing and collaboration transactions look like that often underpin companies contemplating a listing?
  • How are the public listings that are getting done being planned and structured?

Confirmed speakers on one panel include Britt Meelby Jensen from Zealand Pharma, Anders Hinsby from Orphazyme and Alex Haahr from Nuevolution – three companies that have carried out listings in NY, Stockholm and CPH, respectively. More to be announced.

You can read more and register on www.CPHlifescience.com.